Tirzepatide is a groundbreaking new medication designed to control type 2 diabetes. This injectable drug works by mimicking two naturally occurring hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). By stimulating the production of insulin and reducing glucagon release, tirzepatide effectively regulate